Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 2008 Nov 11;99(11):1940–1945. doi: 10.1038/sj.bjc.6604775

Breast cancer incidence following low-dose rate environmental exposure: Techa River Cohort, 1956–2004

E Ostroumova 1,2,*, D L Preston 3, E Ron 1, L Krestinina 2, F G Davis 4, M Kossenko 2,5, A Akleyev 2
PMCID: PMC2600704  PMID: 19002173

Abstract

In the 1950s, the Mayak nuclear weapons facility in Russia discharged liquid radioactive wastes into the Techa River causing exposure of riverside residents to protracted low-to-moderate doses of radiation. Almost 10 000 women received estimated doses to the stomach of up to 0.47 Gray (Gy) (mean dose=0.04 Gy) from external γ-exposure and 137Cs incorporation. We have been following this population for cancer incidence and mortality and as in the general Russian population, we found a significant temporal trend of breast cancer incidence. A significant linear radiation dose–response relationship was observed (P=0.01) with an estimated excess relative risk per Gray (ERR/Gy) of 5.00 (95% confidence interval (CI), 0.80, 12.76). We estimated that approximately 12% of the 109 observed cases could be attributed to radiation.

Keywords: breast cancer, incidence, ionising radiation, low-dose rate exposure, Techa River


The female breast is recognised as one of the most radiation-sensitive organs and exposure to ionising radiation appears to play a role in both the initiation and promotion of breast cancer (UNSCEAR, 2000). Increased risk of breast cancer was reported in women exposed to multiple X-ray examinations (Boice et al, 1991; Doody et al, 2000), radiotherapy (Hildreth et al, 1989; Mattsson et al, 1993; Lundell et al, 1999) and radiation from the atomic bombings in Japan (Land et al, 2003; Preston et al, 2007). The atomic bombings and fractionated medical X-radiation are characterised by acute, high-dose rate γ-radiation. In a pooled analysis of several cohorts, an excess relative risk (ERR) per Gray (Gy) of 0.86 (95% confidence interval (CI), 0.7, 1.04) was reported with individual study risks ranging from 0.06 to 1.94 (Preston et al, 2002).

In contrast, risks from exposure to chronic low-dose rate radiation have rarely been quantified due to a lack of adequate dose estimates. Associations between cancer risks from low-dose occupational radiation exposure (Wang et al, 2002; Doody et al, 2006) or protracted low-to-moderate dose environmental radiation exposure (Bauer et al, 2005; Pukkala et al, 2006) have, however, been reported.

In this paper, we report on the breast cancer experience among women who were exposed to protracted low-dose rate external and internal radiation from discharges of radioactive waste into the Techa-Iset river system from the Mayak nuclear weapons facility in the Southern Urals region of Russia. These releases primarily occurred between 1950 and 1960, affecting tens of thousands of inhabitants of riverside villages. The study was reviewed and approved by the institutional review board at the Urals Research Center for Radiation Medicine (URCRM).

Materials and methods

Study cohort

The Techa River Incidence cohort (TRIC) consists of 18 382 individuals born before 1950, who lived in villages on the Techa River in Chelyabinsk Oblast at some time between January 1950 and December 1960. The current analyses are based on the 9908 female cohort members with follow-up from 1956–2004. The study cohort and follow-up period were defined on the basis of the cancer incidence data availability.

The discharge of radioactive wastes into the Techa-Iset river system was the source of a substantial radiation exposure. The total volume of radioactive wastes discharged by the Mayak facility amounted to 76 million m3 with a total activity of 1017 Bq (2.75 million Ci) for β-emitters (Akleyev and Lyubchansky, 1994). About 95% of the total activity was released into the Techa River from March 1950 through November 1951. The primary radionuclides released were 137Cs and the bone-seeking isotopes of strontium (89Sr and 90Sr), which accounted for 12.2 and 20.4% of the total discharge, respectively (Degteva et al, 1994).

Residents of the riverside areas received both external and internal radiation exposures. External exposures to γ-radiation were primarily from 137Cs, with some additional exposure from 106Ru, 95Zr. Internal exposures largely resulted from use of river water contaminated with 137Cs, 89Sr, and 90Sr for drinking, cooking and other domestic needs (Degteva et al, 1994). Details of the Techa River Dosimetry System (TRDS-2000) used to reconstruct external and internal doses are published elsewhere (Degteva et al, 2000a, 2000b; Jacob et al, 2003). Exposure of soft tissues, including breast, was largely from external γ-radiation and internal γ-radiation from 137Cs distributed uniformly through the body. In the absence of individual breast dose estimates, individualised estimates of doses to the stomach are used as an approximation of dose to breast. The TRDS-2000 provides annual dose estimates based primarily on age- and village-specific group means that were individualised to account for the periods of residence in contaminated villages. The maximum estimated dose to the stomach was 0.47 Gy (mean=0.04 Gy; median=0.01 Gy).

Considerable migration among study cohort members because of compulsory re-settlement from highly contaminated to uncontaminated villages, and migration of younger cohort members primarily for educational or job opportunities presented a challenge in follow-up and therefore most work has focused on mortality data (Kossenko et al, 2005; Krestinina et al, 2005). Information on date and place of death, current residence and the date and place of migration of cohort members was obtained through periodic queries to the Address Bureaus of Chelyabinsk and Kurgan Oblasts. Because of the difficulties in obtaining cancer incidence data, we limited follow-up to the five rayons (districts) in Chelyabinsk Oblast where many of the exposed subjects resided and to Chelyabinsk city. These six geographic areas are considered the cancer incidence study catchment area.

Reporting of newly diagnosed malignancies to the Regional Oncology Dispensaries using notification forms became mandatory in the former Soviet Union in 1956. URCRM staff have systematically collected copies of cancer notification forms for residents of the study catchment area. As the probability of identifying a cancer case depended on a cohort member living in the study catchment area, only breast cancers diagnosed while the patient lived in the catchment area are included in the analysis. Cohort members are treated as lost to follow-up when they migrate from the catchment area (Kossenko et al, 2005; Krestinina et al, 2007).

Basic personal identifiers (last name, first name and father's first name, birth date, place of birth) are used for matching cancer case notifications to the TRIC. Copies of death certificates for deceased cohort members are obtained from the Regional Vital Statistics Registrar's Office archives. Additional information on cohort members who developed breast cancer is obtained from their medical charts stored at the URCRM clinical department.

Statistical methods

Analyses were based on a detailed classification of person-years and case counts stratified by ethnic group (Slavs and Tartars/Bashkirs), attained age (5-year groups through age 79 and 80 plus), follow-up period (5-year periods from 1956 through 2004), age at first exposure (10-year groups through age 59 and 60 plus), time of study entry (before and after 1.1.1953), number of live births (nulliparous, 1–2, ⩾3 children and unknown), age at first pregnancy (<25, ⩾25 years and unknown), and stomach dose (in Gy) with 5-year latency period, that is, dose received in ⩽5 years prior to cancer diagnosis was not considered in assessing breast cancer risk. The first 6 years of follow-up (1950–1955) were excluded from analysis, because cancer incidence data were not available. Women contributed person-years only when they were known to reside in the catchment area, as this reflected when a woman was at risk of having a breast cancer identified. Person-year accumulation began on 1 January 1956 or from the initial date of residence in a contaminated village after that date. The termination date for counting person-years was the date of death, or the earliest of the following: date of last known residence in the catchment area, or of breast cancer diagnosis, or 31 December 2004. Person-year computations and risk estimation were carried out using Epicure software (Preston et al, 1993).

Statistical analyses and calculation of risk coefficients were based on both external and internal comparisons. For the external comparisons, the number of expected cases was calculated using both general and rural Russian female population age- and calendar-period-specific incidence rates (Tserkovnyi et al, 1975; Napalkov et al, 1982; Merabishvili et al, 1984; Dvoirin et al, 1991; Dvoirin and Aksel, 1992; Chissov and Starinskii, 2000; Chissov et al, 2006). The ratio between observed and expected number of cancers, the standardised incidence ratio (SIR) was calculated with 95% CIs assuming a Poisson distribution.

Breast cancer incidence rates in the cohort were analysed using simple parametric excess relative risk (ERR) models. The basic ERR model for age-specific breast cancer incidence rates was λ(a, d, z)=λ0(a, z0)(1+ρ(d)ε(z1)) where a is age at diagnosis, d is stomach dose in Gy, z0 represents factors (such as birth cohort, parity, age at first full-term pregnancy, ethnicity or date of arrival on the contaminated area) that could modify the baseline rates (λ0), and z1 represents factors that could modify the ERR. For analyses based on external comparisons the baseline rates were taken to be equal to the θRpop(a,y), where Rpop(a,y) is the population rate for age a in year y, and θ is the estimated baseline SIR. For analyses based on internal comparisons, a log linear model was used to estimate baseline (zero-dose) risk with the rates to be proportional to age to a power that changes once women reach the age of 50 years. Ethnicity, number of live births, time of study entry and birth cohort were considered as potential modifiers of the baseline rates.

The dose–response function was generally taken as a linear function of dose (ρ1d). Tests for non-linearity in the dose–response were based on comparison of the linear and linear-quadratic dose–response models (ρ1d2d2). Because of the small number of observed and radiation-associated cases in this cohort, there is little power to assess effect modification. The primary analysis was based on a dose–response model without effect modification. However, we evaluated several factors that might modify the association between radiation and breast cancer, namely, age at exposure, ethnicity and age at diagnosis.

Parameter estimates were obtained using Poisson regression maximum likelihood analyses of rates in the detailed rate tables described above. Significance tests and CIs were determined directly from the likelihood. All P-values refer to two-sided tests.

Results

Over 37 years (1956–2004), 109 breast cancers were diagnosed among TRIC members, of which 79% were histologically confirmed, 16% by X-ray and clinical examinations, and 5% solely from death certificates.

The majority of cohort members reported Slavic ethnicity (67%), 42% of women were less than 20 years old at the start of exposure, and 79% lived along the river during the period of maximum releases (i.e., 1950–1952). At the end of follow-up 19% of the cohort were urban residents. The estimated stomach doses were below 5 mGy for 30% of the cohort members, whereas 16% had a dose of 50 mGy and over.

Table 1 summarises the follow-up status of the study cohort. The 9908 study subjects have a total of 270 289 person-years of follow-up in the catchment area during the study period. At the end of the follow-up period, 2115 (21%) cohort members were known to have migrated from the catchment area. Owing to lack of complete cancer incidence data outside the catchment area, as well as the differences in follow-up within and outside this area (vital status unknown for 37% of migrants vs 8% of non-migrants; cause of death unknown for 41% of deceased outside vs 13% of deceased within the catchment area), the analyses were limited to the periods in which cohort members were known to reside in the catchment area.

Table 1. Distribution of vital status in the Techa River Incidence female cohort by residence for subjects with and without breast cancer (follow-up period 1.1.1956–31.12.2004).

Vital status as of 31.12.2004 Cancer incidence catchment areaa (%) Outside the catchment area (%) Total (%)
Non cases (n=9777)
 Alive 2666–34.2 611–28.9 3277–33.1
 Dead 4372–56.1 701–33.1 5073–51.2
  Cause known 3820–87 412–59 4232–83
  Cause unknown 552–13 289–41 841–17
 Current vital status unknown 646–8.3 781–36.9 1427–14.4
       
Breast cancer cases (n=131)
 Alive 41 4 45
 Dead 66 18 84
  Cause known 62 17 79
  Cause unknown 4 1 5
 Current vital status unknown 2 0 2
 Total 7793–100 2115–100 9908–100
 Person-years 270289 57684 327973
a

Cancer incidence catchment area includes four rayons through which Techa River flows (Kaslinsky, Krasnoarmeysky, Kunashaksky and Argayshsky) and Sosnovsky rayon where many exposed residents were resettled and Chelyabinsk city to which many of the cohort members moved.

Table 2 shows crude breast cancer incidence rates and adjusted relative risks by follow-up period. The crude rates increased with follow-up period primarily due to the aging of the cohort. The increase in baseline incidence rates prior to and after 50 years of age was proportional to the 6.8 and 1.1 power of age, respectively. After adjusting for attained age, we found a marked birth cohort effect (P<0.001) with rates increasing on average by 50% (95% CI: 28; 87%) per decade increase of birth year. Without allowing for possible radiation dose effects, the number of cases was 37% more than predicted national rates for rural areas (109 observed vs 79.6 expected, SIR=1.37; 95% CI: 1.13; 1.65). However, when compared with general female population rates the observed number of cases was 19% lower than expected (109 vs 135.3, SIR=0.81; 95% CI: 0.67; 0.97). Allowing for a linear dose–response, the baseline SIRs were somewhat lower, with estimates of 1.26 (rural) (95% CI: 1.01; 1.58) and 0.74 (general) (95% CI: 0.59; 0.93), respectively. Breast cancer SIRs based on Russian general and rural female population rates by follow-up period are presented in Figure 1.

Table 2. Breast cancer incidence rates and relative risks by times of tumour diagnosis in the Techa River Incidence female cohort.

Follow-up period Number of cases Number of person-years Mean age, years Crude rate per 105 PYR (95% CI) RRa (95% CI)
1956–1969 13 108300 39.4 12.0 (7.0–20.7) 1.0
1970–1979 14 61056 48.9 22.9 (13.6–38.7) 1.3 (0.6–2.9)
1980–1989 30 48847 55.7 61.4 (42.9–87.8) 2.86 (1.5–5.5)
1990–2004 52 52086 63.5 99.8 (76.17–131.0) 3.9 (2.1–7.7)
1956–2004 109 270289 49.1 40.3 (33.448.7)  
a

Relative risk adjusted for age at diagnosis, ethnicity, number of children, time of arrival on the contaminated territory (before and after 1953) and 5-year lagged cumulative stomach dose based on linear ERR model.

Figure 1.

Figure 1

Standardised Incidence Ratios (SIRs) and 95% confidence intervals (CIs) for breast cancer for the Techa River female population compared with Russian general (open circles) and rural (black circles) female populations by follow-up period. Lines represent overall SIR estimate for the Techa River female population compared with Russian rural (upper, dot-dashed line) and Russian general (lower, dashed line) female populations. x axis – Follow-up year; y axis – SIR.

Table 3 summarises relative risk estimates for selected non-radiation risk factors. Background breast cancer risk among Tartar and Bashkir was 34% lower than Slavic women (P=0.06). A significantly higher risk was found among women who arrived on the Techa River between 1953 and 1960 (i.e., late entrants) compared with those who lived in the area during the period of maximal radioactive contamination. The highest breast cancer risk was found in nulliparous women compared with women who had three or more children (P=0.008). Among parous women, there was no difference in risk by age at first birth (P=0.43).

Table 3. Breast cancer incidence risk estimates.

Risk factor Cases n=109 PYR n=270289 RRa 95% CI
Ethnicity        
 Slavs 78 165456 1.0 Referent
 Tartars & Bashkirs 31 104833 0.7 0.4–1.0
P for homogeneity 0.06, d.f.=1
 
Subcohort        
 OTRCb 82 221848 1.0 Referent
 Late entrants 27 48441 1.7 1.03–2.6
P for homogeneity 0.04, d.f.=1
 
Attained age, years:
 <45 12 110730 0.1 0.1–0.2
 45–54 33 52585 1.0 Referent
 55–64 34 50453 1.3 0.8–2.2
 65+ 30 56521 1.7 1.0–3.0
P for homogeneity <0.001, d.f.=3
 
Number of children born c
 3+ 36 124060 1.0 Referent
 1–2 53 104546 1.8 1.1–2.7
 Nulliparous 19 36483 2.2 1.2–3.8
P for homogeneity 0.008, d.f.=2
 
Age at first pregnancy c
 <20 years 8 27123 1.0 Referent
 ⩾20 years 81 200998 1.3 0.7–3.0
P for homogeneity 0.43, d.f.=1
a

Relative risk adjusted for age at diagnosis, ethnicity, number of children, age at first pregnancy, time of arrival on the contaminated territory (before and after 1953), linear birth cohort effect and 5-year lagged cumulative stomach dose based on linear ERR model.

b

OTRC=Original Techa River Cohort (resident in the Techa area in 1950–1952).

c

One case with unknown information on live birth and age at first pregnancy is excluded from analysis.

A significant (P=0.01) linear dose–response relationship was observed for breast cancer with little evidence of non-linearity (P>0.5). The estimated ERR/Gy was 4.99 (95% CI: 0.80; 12.76). Table 4 summarises the distribution of cases, person-years and fitted values in 5-year lagged cumulative dose categories.

Table 4. Breast cancer 1956–2004 by stomach dose category.

Dosea (mGy) Person years Cases Backgroundb Excessb(95% CI) %ARc(95% CI)
<5.0 67631 25 30.7 0.3 (0.04–0.6) 1.2 (0.2–2.4)
5–9.9 75460 37 29.7 1.0 (0.2–2.1) 2.7 (0.5–5.7)
10–24.9 41377 8 10.5 1.1 (0.2–2.2) 13.7 (2.5–27.5)
25–49.9 48453 19 14.4 2.0 (0.4–4.1) 10.5 (2.1–21.6)
50+ 37368 20 10.1 9.1 (1.7–18.7) 45.5 (8.5–93.5)
Total 270289 109 95.5 13.5 (2.5–27.8) 12.4 (2.3–25.5)
a

5-year lagged cumulative stomach dose.

b

Estimates of the number of background and radiation-associated excess cases based on a linear ERR model after background rates adjustment for effects of age, number of children, time of arrival on the contaminated territory (before and after 1953) and linear birth cohort effect.

c

AR–attributable risk estimated as the ratio of the number radiation-associated excess cases over the total number of cases in each stomach dose category.

Under a linear dose–response model, it was estimated that 12.4% (95% CI: 2.3; 25.5%) of the breast cancers observed were attributable to radiation exposure. The small number of breast cancers limited the ability to detect effect modification. Ethnicity, age at diagnosis, age at exposure and time since exposure did not significantly modify the breast cancer radiation risk estimate; however, women who were under age 10 at first exposure appeared to have the highest risk (data not shown).

Discussion

This is the first report describing breast cancer incidence patterns and radiation dose relations in a subgroup of the Techa River cohort. The main result from our study was a significant linear relationship between breast cancer incidence and radiation dose. This finding adds to the limited data on the carcinogenic effects from protracted environmental ionising radiation in the low-to-medium dose range.

As neither Techa River residents nor health care providers were aware of dose levels and given the legal requirement for newly diagnosed malignancies to be reported to the Regional Oncology Dispensary, the likelihood of differential reporting for patients with high and low exposure is small. The power of the study is decreased by the reduction in person-years of follow-up because of relatively high migration from the study catchment area. Because of the nature of the address and cancer registration systems it is not possible to obtain complete information on cancer incidence, vital status or cause of death for cohort members living outside the study catchment area. For cohort members living in the study catchment area, vital status at the end of follow-up was known for 92% and among deceased subjects cause of death was ascertained for 87% (Table 1). However, vital status at the end of follow-up was known for only 63% of cohort members who had left the catchment area and cause of death was known for only 60% of the identified. Therefore, analyses were limited to periods in which subjects were known to reside in the study catchment area. The loss to follow-up reduces the study's statistical power to detect a dose–response and assess effect modification. It could introduce some bias, but as there is no indication that the loss to follow-up is dose-related, bias is unlikely. In our study, 79% of breast cancers had histological confirmation and 5% were identified only through death certificates. This is comparable with the respective indices in Eastern Europe cancer registries (IARC, 1992).

We found a significant increase of breast cancer background risk with attained age, nulliparity, and follow-up time, as in the general Russian population and worldwide (Remennick, 1989; Zaridze and Basieva, 1990; IARC, 1993). Although national data are limited, the striking birth cohort effect in our study appears to be consistent with that in the Russian Federation as a whole during this period (Tserkovnyi et al, 1975; Napalkov et al, 1982; Merabishvili et al, 1984; Dvoirin et al, 1991; Dvoirin and Aksel, 1992; Chissov and Starinskii, 2000; Chissov et al, 2006).

The failure to find a significant effect of age at first full-term pregnancy can be attributed to the fact that 97% of women in our study were under 30 years of age at the time of their first full-term pregnancy. After adjustment for the number of live births, the difference between the two ethnic groups (Slavs vs Tartars and Bashkirs) was marginally significant (P=0.06) suggesting that this is largely because of different reproductive patterns (Remennick, 1989). The reason for higher background breast cancer risk among late entrants compared with women resident in the Techa area in 1950–1952, is not clear and requires further investigation.

We recognise the possible underascertainment of breast cancers in our cohort because of the retrospective nature of our follow-up, most likely in women 70 years and older. Breast cancer SIR estimates were somewhat higher (SIR=1.37; 95% CI: 1.13; 1.65) using Russian rural rates, and lower (SIR=0.81; 95% CI: 0.67; 0.97) with the general Russian rates were used.

One of the main limitations in our study was the relatively low statistical power for quantifying how the radiation risk varies with age at exposure, age at diagnosis and ethnicity. Although it is significant, the point estimate of the ERR per Gy of 4.99 is quite uncertain with 95% CI, 0.80, 12.76. Although the TRDS-2000 does not provide breast dose estimates, because of the nature of the soft tissue exposures (external γ-ray exposures and internal exposure to γ-rays from 137Cs distributed uniformly throughout the body), the breast and stomach doses should be similar. TRDS-2000 dose estimates should not be considered definitive, as efforts are currently underway to improve the dosimetry system by better characterisation of the radiation source term and using more information to individualise dose estimates (Degteva et al, 2006).

On account of the overlapping CIs, our risk estimate, though higher, is comparable with the ERR of 0.86/Gy (95% CI: 0.7; 1.04) found in the pooled analysis of atomic bomb survivors and seven cohorts of medically irradiated women with 1502 breast cancers and 1.8 million person-years of follow-up (Preston et al, 2002). Among the cohorts considered in that study, the highest ERR (1.94/Gy with a 95% CI of 1.3–2.8) was observed in the Swedish benign breast disease cohort (mean breast dose=5.8 Gy).

Significantly elevated breast cancer risks were reported for a cohort of 56 436 US radiologic technologists (Doody et al, 2006) and among 5443 Chinese female X-ray workers (Wang et al, 2002) who experienced daily, small radiation doses over many years. In both of these cohorts the highest relative risks appeared to be among women who were younger at the time of initial exposure. A meta-analysis of breast cancer incidence among female flight attendants suggested a significant increase in risk due to occupational exposure to cosmic radiation (Tokumaru et al, 2006). Rafnsson et al (2001) also found an increased breast cancer risk among 1690 flight attendants with 26 breast cancers (SIR=1.5, 95% CI: 1.0; 2.4) at the mean annual radiation dose of about 3 mSv. The authors suggested that the doses appeared to be too low to explain the increased risk and stated that adjustment for other occupational hazards (e.g., exposure to chemicals, irregular work hours etc.) was necessary.

Analysis of 61 breast cancers in almost 5000 women exposed to radiation from nuclear testing fallout in Kazakhstan (mean effective dose=634 mSv), provided an ERR of 1.09/Sv (95% CI: −0.05; 15.8) (Bauer et al, 2005). A study of breast cancer incidence after the Chernobyl accident found an increased risk among women resident in the most contaminated districts (average cumulative whole body dose of 50 mSv) with an ERR of 1.2 (95% CI, 0.5, 2.3) in Belarus and 0.8 in Ukraine (95% CI: 0.1; 1.9). However, the limitations of ecologic studies require that this finding be interpreted with caution (Pukkala et al, 2006).

Our study findings are in agreement with the hypothesis of linearity of radiation dose–response for breast cancer. The point estimate of the ERR per Gy is higher than that reported by others, but given our wide risk CIs, it is consistent with many other studies. Current dose estimates have limitations that could bias ERR estimates (Degteva et al, 2006). Planned improvements to the dosimetry system include: (1) use of modified source term based on information on the timing and composition of the Mayak nuclear facility releases: (2) taking account of the precise location of subjects' residence rather than the current use of a representative location for each village (an important factor for external dose); (3) using improved information on an individual's source of drinking water (affecting internal dose); (4) making more direct use of individual whole body count data in estimation of internal doses; (5) taking into account other sources of radiation exposure, such as the 1957 Kyshtym accident, radioactive gaseous aerosol releases from the Mayak nuclear facility, and exposure from radiological medical examinations. Although these changes will reduce uncertainty of individual dose estimates, they are not expected to substantially modify risk estimates.

In summary, an analysis of breast cancer incidence among women in the Techa River Incidence Cohort has shown a significant increase with age at diagnosis, birth cohort and reduction in incidence with increasing parity. A significant linear trend of risk with increasing radiation dose, is based on small numbers and requires cautious interpretation.

Acknowledgments

As with any long-term large-scale projects, many people have made important contributions to this study. We are grateful for the support of the Chelyabinsk Oblast Oncology Dispensary. We acknowledge the contributions of Nickolai Startsev, Marina Degteva, Catherine Zhidkova, Daniel Hoffman and the late Terry Thomas. Financial support has been provided by the Russian Ministry of Health, the Russian Federal Medical-Biological Agency and the United States Department of Energy (Contract DE-FC02-04EH04014).

References

  1. Akleyev AV, Lyubchansky ER (1994) Environmental and medical effects of nuclear weapon production in the Southern Urals. Sci Total Environ 142: 1–8 [DOI] [PubMed] [Google Scholar]
  2. Bauer S, Gusev BI, Pivina LM, Apsalikov KN, Grosche B (2005) Radiation exposure due to local fallout from Soviet atmospheric nuclear weapons testing in Kazakhstan: solid cancer mortality in the Semipalatinsk historical cohort, 1960-1999. Radiat Res 164: 409–419 [DOI] [PubMed] [Google Scholar]
  3. Boice Jr JD, Preston D, Davis FG, Monson RR (1991) Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat Res 125: 214–222 [PubMed] [Google Scholar]
  4. Chissov VI, Starinskii VV (2000) Malignant neoplasms in Russia in 1999 (morbidity and mortality). PA Hertzen Cancer Research Institute: Moscow. Russian [Google Scholar]
  5. Chissov VI, Starinskii VV, Petrova GV (2006) Malignant neoplasms in Russia in 2004 (morbidity and mortality). PA Hertzen Cancer Research Institute: Moscow. Russian [Google Scholar]
  6. Degteva MO, Kozheurov VP, Tolstych EI, Vorobiova MI, Anspaugh LR, Napier BA, Kovtun AN (2000a) The Techa River dosimetry system: methods for the reconstruction of internal dose. Health Phys 79: 24–35 [DOI] [PubMed] [Google Scholar]
  7. Degteva MO, Kozheurov VP, Vorobiova MI (1994) General approach to dose reconstruction in the population exposed as a result of the release of radioactive wastes into the Techa River. Sci Total Environ 142: 49–61 [DOI] [PubMed] [Google Scholar]
  8. Degteva MO, Vorobiova MI, Kozheurov VP, Tolstykh EI, Anspaugh LR, Napier BA (2000b) Dose reconstruction system for the exposed population living along the Techa River. Health Phys 78: 542–554 [DOI] [PubMed] [Google Scholar]
  9. Degteva MO, Vorobiova MI, Tolstykh EI, Shagina NB, Shishkina EA, Anspaugh LR, Napier BA, Bougrov NG, Shved VA, Tokareva EE (2006) Development of an improved dose reconstruction system for the Techa River population affected by the operation of the Mayak Production Association. Radiat Res 166: 255–270 [DOI] [PubMed] [Google Scholar]
  10. Doody MM, Freedman MD, Alexander BH, Hauptmann M, Miller JS, Rao RS, Mabuchi K, Ron E, Sigurdson AJ, Linet MS (2006) Breast cancer incidence in US radiologic technologists. Cancer 106: 2707–2715 [DOI] [PubMed] [Google Scholar]
  11. Doody MM, Lonstein JE, Stovall M, Hacker DG, Luckyanov N, Land CE (2000) Breast cancer mortality after diagnostic radiography: findings from the U. S. Scoliosis Cohort Study. Spine 25: 2052–2063 [DOI] [PubMed] [Google Scholar]
  12. Dvoirin VV, Aksel EM (1992) The malignant neoplasm morbidity of the population of Russia in 1990. Vopr Onkol 38: 1413–1483. Russian [PubMed] [Google Scholar]
  13. Dvoirin VV, Tserkovnyi GF, Aksel EM (1991) Malignant neoplasm morbidity in the USSR in 1985–1989. Vopr Onkol 37: 401–436. Russian [PubMed] [Google Scholar]
  14. Hildreth NG, Shore RE, Dvoretsky PM (1989) The risk of breast cancer after irradiation of the thymus in infancy. N Engl J Med 321: 1281–1284 [DOI] [PubMed] [Google Scholar]
  15. International Agency for Research on Cancer (IARC) (1992) Cancer incidence in five continents. 120. IARC Press: Lyon, France [Google Scholar]
  16. International Agency for Research on Cancer (IARC) (1993) Trends in cancer incidence and mortality. 121. IARC Press: Lyon, France [Google Scholar]
  17. Jacob P, Göksu Y, Taranenko V, Meckbach R, Bougrov NG, Degteva MO, Vorobiova MI (2003) On an evaluation of external dose values in the Techa River Dosimetry System (TRDS) 2000. Radiat Environ Biophys 42: 169–174 [DOI] [PubMed] [Google Scholar]
  18. Kossenko MM, Thomas TL, Akleyev AV, Krestinina LY, Startsev NV, Vyushkova OV, Zhidkova CM, Hoffman DA, Preston DL, Davis F, Ron E (2005) The Techa River Cohort: study design and follow-up methods. Radiat Res 164: 591–601 [DOI] [PubMed] [Google Scholar]
  19. Krestinina LY, Davis F, Ostroumova EV, Epifanova SB, Degteva MO, Preston DL, Akleyev AV (2007) Solid cancer incidence and low-dose-rate radiation exposures in the Techa River cohort: 1956–2002. Intl J Epidemiol 36: 1038–1046 [DOI] [PubMed] [Google Scholar]
  20. Krestinina LY, Preston DL, Ostroumova EV, Degteva MO, Ron E, Vyushkova OV, Startsev NV, Kossenko MM, Akleyev AV (2005) Protracted radiation exposure and cancer mortality in the Techa River Cohort. Radiat Res 164: 602–611 [DOI] [PubMed] [Google Scholar]
  21. Land CE, Tokunaga M, Koyama K, Soda M, Preston DL, Nishimori I, Tokuoka S (2003) Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950–1990. Radiat Res 160: 707–717 [DOI] [PubMed] [Google Scholar]
  22. Lundell M, Mattsson A, Karlsson P, Holmberg E, Gustafsson A, Holm LE (1999) Breast cancer risk after radiotherapy in infancy: a pooled analysis of two Swedish cohorts of 17 202 infants. Radiat Res 151: 626–632 [PubMed] [Google Scholar]
  23. Mattsson A, Rudén BI, Hall P, Wilking N, Rutqvist LE (1993) Radiation-induced breast cancer: long-term follow-up of radiation therapy for benign breast disease. J Natl Cancer Inst 85: 1679–1685 [DOI] [PubMed] [Google Scholar]
  24. Merabishvili VM, Semiglazov VF, Serova LS, Buslayeva MM (1984) Geographical distribution of breast cancer in the USSR. Int J Cancer 34: 71–75 [DOI] [PubMed] [Google Scholar]
  25. Napalkov NP, Merabishvili VM, Tserkovnyi GF, Preobrazhenskaya MN (1982) Malignant neoplasm morbidity of the population of the USSR for the period 1970–1980. Vopr Onkol 28: 26–71. Russian [PubMed] [Google Scholar]
  26. Preston DL, Lubin JH, Pierce DA, McConney ME (1993) EPICURE. HiroSoft International Corporation: Seattle, USA [Google Scholar]
  27. Preston DL, Mattsson A, Holmberg E, Shore R, Hildreth NG, Boice Jr JD (2002) Radiation effects on breast cancer risk: a pooled analysis of eight cohorts. Radiat Res 158: 220–235 [DOI] [PubMed] [Google Scholar]
  28. Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, Mabuchi K, Kodama K (2007) Solid cancer incidence in atomic bomb survivors: 1958–1998. Radiat Res 168: 1–64 [DOI] [PubMed] [Google Scholar]
  29. Pukkala E, Kesminiene A, Poliakov S, Ryzhov A, Drozdovitch V, Kovgan L, Kyyrönen P, Malakhova I, Gulak L, Cardis E (2006) Breast cancer in Belarus and Ukraine after the Chernobyl accident. Int J Cancer 119: 651–658 [DOI] [PubMed] [Google Scholar]
  30. Rafnsson V, Tulinius H, Jónasson JG, Hrafnkelsson J (2001) Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control 12: 95–101 [DOI] [PubMed] [Google Scholar]
  31. Remennick L (1989) Reproductive patterns and cancer incidence in women: a population-based correlation study in the USSR. Int J Epidemiol 18: 498–510 [DOI] [PubMed] [Google Scholar]
  32. Tokumaru O, Haruki K, Bacal K, Katagiri T, Yamamoto T, Sakurai Y (2006) Incidence of cancer among female flight attendants: a meta-analysis. J Travel Med 13: 127–132 [DOI] [PubMed] [Google Scholar]
  33. Tserkovnyi GF, Napalkov NP, Berezkin DP, Preobrazhenskaya MN, Shabashova NI (1975) Malignant neoplasm morbidity among the population of the USSR. Vopr Onkol 21: 3–16. Russian [PubMed] [Google Scholar]
  34. UNSCEAR (2000) Sources and effects of ionizing radiation. United Nations: New York [DOI] [PubMed] [Google Scholar]
  35. Wang JX, Zhang LA, Li BX, Zhao YC, Wang ZQ, Zhang JY, Aoyama T (2002) Cancer incidence and risk estimation among medical X-ray workers in China, 1950–1995. Health Phys 82: 455–466 [DOI] [PubMed] [Google Scholar]
  36. Zaridze D, Basieva T (1990) Incidence of cancer of the lung, stomach, breast and cervix in the USSR: pattern and trends. Cancer Causes Control 1: 39–49 [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES